FRF-001

· FOXG1 Research Foundation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FRF-001, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS) [Phase 1, Phase 2]